This review will outline the activation status of PP2A in pulmonary diseases and the subsequent impact on multiple pathways, discuss the potential means of targeting PP2A responses, and possible outcomes of targeting PP2A activity systemically. The gene discussed is PTPA; the disease is lung disorder.